Asthmapolis CEO to Present at Respiratory Drug Delivery (RDD®) Europe 2013
Published: May 20, 2013
MADISON, Wis., May 20, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-o-lis), the FDA-cleared mobile health solution for asthma and COPD, today announced CEO David Van Sickle will give an invited presentation during Respiratory Drug Delivery (RDD®) Europe 2013 in Berlin, Germany. On Friday, May 24 at 8:30 a.m., Van Sickle will present "Monitoring and Improving Compliance and Asthma Control: Mapping Inhaler Use for Feedback to Patients, Physicians and Payers" as part of the session track, "Designing Devices for the Marketplace."
RDD Europe is a major scientific conference that will welcome pulmonary and nasal drug delivery experts from around the world. RDD conferences take place in both Europe and the USA in alternate years and are widely regarded as the premier venue for presenting the latest pulmonary and nasal drug delivery advances. The scientific symposium will bring together an audience of high level academic, industrial and regulatory experts involved in the research, development, investigation and marketing of existing and new therapies for delivery through the nose or lungs.
Van Sickle will discuss how Asthmapolis aims to improve the care of people with asthma, advance understanding of symptoms and triggers and help them achieve control of the disease. It uses a novel combination of smartphone applications and snap-on inhaler sensors that track when and how often patients use their inhaled medications. The geomedicine platform, available in both English and Spanish, is designed to help individuals with their daily preventive medications, reveal insights about their use of rescue medications and provide personalized feedback to improve their ability to successfully manage the disease.
Users receive ongoing educational outreach through email, text, mobile apps and phone support from a certified asthma educator. People who opt in may also share information about their medication use with their health care provider, giving them the ability to monitor whether their treatment is truly controlling symptoms.
Founded in 2010, Asthmapolis aims to improve the management of chronic respiratory disease for people and healthcare professionals. Backed by The Social+Capital Partnership, California HealthCare Foundation and other investors, Asthmapolis is now working with organizations like Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida and the City of Louisville. Company recognition includes TEDMED Innovation Showcase, White House Champion of Change and Bluetooth Breakthrough Product awards. The system has been featured in The Economist, Washington Post, Fast Company, Wired and Scientific American. For more information, go to http://asthmapolis.com or email info(at)asthmapolis.com.
Erica St. Angel
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
David Van Sickle